Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1771 AL 1785

Sirtuins and their interactions with transcription factors and poly(ADP-ribose) polymerases

Jęśko H, Strosznajder RP.

Folia Neuropathol. 2016;54(3):212-233. doi: 10.5114/fn.2016.62531.

Is Axonal Degeneration a Key Early Event in Parkinson's Disease?

Kurowska Z, Kordower JH, Stoessl AJ, Burke RE, Brundin P, Yue Z, Brady ST, Milbrandt J, Trapp BD, Sherer TB, Medicetty S.

J Parkinsons Dis. 2016 Oct 19;6(4):703-707. doi: 10.3233/JPD-160881.

The Effects of Physical Activity in Parkinson's Disease: A Review

Lauzé M, Daneault JF, Duval C.

J Parkinsons Dis. 2016 Oct 19;6(4):685-698. doi: 10.3233/JPD-160790.

Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage

Giladi N, Nicholas AP, Asgharnejad M, Dohin E, Woltering F, Bauer L, Poewe W.

J Parkinsons Dis. 2016 Oct 19;6(4):741-749. doi: 10.3233/JPD-160847.

Objectively Assessed Physical Activity and its Association with Balance, Physical Function and Dyskinesia in Parkinson's Disease

Nero H, Benka Wallén M, Franzén E, Conradsson D, Ståhle A, Hagströmer M.

J Parkinsons Dis. 2016 Oct 19;6(4):833-840. doi: 10.3233/JPD-160826.

Statistical Models of Parkinson's Disease Progression: Predictive Validity in a 3-Year Follow-up

Mendes A, Gonçalves A, Vila-Chã N, Calejo M, Moreira I, Fernandes J, Damásio J, Teixeira-Pinto A, Krack P, Lima AB, Cavaco S.

J Parkinsons Dis. 2016 Oct 19;6(4):793-804. doi: 10.3233/JPD-160877.

Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects

Beach TG, Corbillé AG, Letournel F, Kordower JH, Kremer T, Munoz DG, Intorcia A, Hentz J, Adler CH, Sue LI, Walker J, Serrano G, Derkinderen P.

J Parkinsons Dis. 2016 Oct 19;6(4):761-770. doi: 10.3233/JPD-160888.

Professional ethics in complementary and alternative medicines in management of Parkinson's disease

Kim HJ, Jeon B, Chung SJ.

J Parkinsons Dis. 2016 Oct 19;6(4):675-683. doi: 10.3233/JPD-160890.

Loss of independence in early Parkinson disease: A 5-year population-based incident cohort study

Bjornestad A, Tysnes OB, Larsen JP, Alves G.

Neurology. 2016 Oct 11;87(15):1599-1606. doi: 10.1212/WNL.0000000000003213. Epub 2016 Sep 2.

Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303)

Isaacson S, Shill HA, Vernino S, Ziemann A, Rowse GJ.

J Parkinsons Dis. 2016 Oct 19;6(4):751-759. doi: 10.3233/JPD-160860.

Personalized Medicine Approaches in Parkinson's Disease: The Genetic Perspective

Gasser T.

J Parkinsons Dis. 2016 Oct 19;6(4):699-701. doi: 10.3233/JPD-160876.

The Practicalities of Assessing Freezing of Gait

Barthel C, Mallia E, Debû B, Bloem BR, Ferraye MU.

J Parkinsons Dis. 2016 Oct 19;6(4):667-674. doi: 10.3233/JPD-160927.

Diffusion alterations associated with Parkinson's disease symptomatology: A review of the literature

Hall JM, Ehgoetz Martens KA, Walton CC, O'Callaghan C, Keller PE, Lewis SJ, Moustafa AA.

Parkinsonism Relat Disord. 2016 Dec;33:12-26. doi: 10.1016/j.parkreldis.2016.09.026. Epub 2016 Sep 28.

The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication

Evens R, Hoefler M, Biber K, Lueken U.

Neuropsychologia. 2016 Oct;91:163-172. doi: 10.1016/j.neuropsychologia.2016.07.032. Epub 2016 Jul 27.

Insulin resistance and Parkinson's disease: A new target for disease modification?

Athauda D, Foltynie T.

Prog Neurobiol. 2016 Oct-Nov;145-146:98-120. doi: 10.1016/j.pneurobio.2016.10.001. Epub 2016 Oct 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias